Author details

Full Name

Shuang Huang

Affiliation

ORCID

Career Start Year

1995

Papers

100

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35188043	Production of active human FGF21 using tobacco mosaic virus-based transient expression system.	Growth Factors	2021
32820156	Addiction to protein kinase CÉ© due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer.	Signal Transduction and Targeted Therapy	2020
30209363	Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth.	Oncogene	2019
31643031	MicroRNA-744/transforming growth factor Î²1 relationship regulates liver cirrhosis.	Hepatology International	2019
29581513	The CPLANE protein Intu protects kidneys from ischemia-reperfusion injury by targeting STAT1 for degradation.	Nature Communications	2018
30285892	Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2', 4'-Tetrahydroxychalcone.	J Exp Clin Cancer Res	2018
29416678	MiR-27a as a predictor for the activation of hepatic stellate cells and hepatitis B virus-induced liver cirrhosis.	Oncotarget	2018
28264810	Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast Cancers.	Cancer Immunol Res	2017
28709638	DNA methylation protects against cisplatin-induced kidney injury by regulating specific genes, including interferon regulatory factor 8.	Kidney International	2017
28435472	Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth.	Theranostics	2017
27617576	Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways.	Oncogene	2017
28069043	FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib.	Journal of Experimental and Clinical Cancer Research	2017
27901486	Triple negative breast cancer development can be selectively suppressed by sustaining an elevated level of cellular cyclic AMP through simultaneously blocking its efflux and decomposition.	Oncotarget	2016
27085092	Cyclin E1-CDK 2, a potential anticancer target.	Aging	2016
27213581	ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling.	Oncotarget	2016
27123926	Persistent activation of autophagy in kidney tubular cells promotes renal interstitial fibrosis during unilateral ureteral obstruction.		2016
26774480	KDM4C and ATF4 Cooperate in Transcriptional Control of Amino Acid Metabolism.	Cell Rep	2016
27705805	Transcriptional Profiling Reveals a Common Metabolic Program in High-Risk Human Neuroblastoma and Mouse Neuroblastoma Sphere-Forming Cells.	Cell Rep	2016
27984128	DNA damage response in nephrotoxic and ischemic kidney injury.	Toxicology and Applied Pharmacology	2016
26204491	Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression.	Oncotarget	2015
25553462	E3 ubiquitin ligase Skp2 as an attractive target in cancer therapy.	Frontiers in Bioscience - Landmark	2015
25828376	Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis.	Expert Opinion on Therapeutic Targets	2015
25428129	mTOR contributes to ER stress and associated apoptosis in renal tubular cells.		2015
26305906	Curcumin Improves the Tumoricidal Effect of Mitomycin C by Suppressing ABCG2 Expression in Stem Cell-Like Breast Cancer Cells.	PLoS ONE	2015
25194819	Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis.	Cellular Signalling	2014
24810778	HOXC8 promotes breast tumorigenesis by transcriptionally facilitating cadherin-11 expression.	Oncotarget	2014
25210800	MEIS2 is essential for neuroblastoma cell survival and proliferation by transcriptional control of M-phase progression.	Cell Death Dis	2014
24746361	SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells.	Neoplasia	2014
23497265	A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells.	Journal of Translational Medicine	2013
22986534	Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression.	Oncogene	2013
24315373	The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation.	Cell Metab	2013
23853661	Current understanding on antihepatocarcinoma effects of xiao chai hu tang and its constituents.	Evidence-based Complementary and Alternative Medicine	2013
24027432	COP1 and GSK3Î² cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis.	Neoplasia	2013
23843896	Role of urokinase receptor in tumor progression and development.	Theranostics	2013
24097974	Human ovarian cancer stroma contains luteinized theca cells harboring tumor suppressor gene GT198 mutations.	Journal of Biological Chemistry	2013
24274069	HOXC9 directly regulates distinct sets of genes to coordinate diverse cellular processes during neuronal differentiation.	BMC Genomics	2013
23482664	Signaling by p38 MAPK stimulates nuclear localization of the microprocessor component p68 for processing of selected primary microRNAs.	Science Signaling	2013
23554832	Circulating miR-583 and miR-663 Refer to ZHENG Differentiation in Chronic Hepatitis B.	Evidence-based Complementary and Alternative Medicine	2013
23255108	Nek1 phosphorylates Von Hippel-Lindau tumor suppressor to promote its proteasomal degradation and ciliary destabilization.	Cell Cycle	2013
22120721	Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression.	Oncogene	2012
22429491	Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim.	Breast Cancer Research	2012
22496418	Regulation of myosin activation during cell-cell contact formation by Par3-Lgl antagonism: entosis without matrix detachment.	Molecular Biology of the Cell	2012
22879880	Functional dissection of HOXD cluster genes in regulation of neuroblastoma cell proliferation and differentiation.	PLoS ONE	2012
23066312	Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B.		2012
21779487	Impaired MicroRNA Processing Facilitates Breast Cancer Cell Invasion by Upregulating Urokinase-Type Plasminogen Activator Expression.	Genes and Cancer	2011
22593800	HOXC8-Dependent Cadherin 11 Expression Facilitates Breast Cancer Cell Migration through Trio and Rac.	Genes and Cancer	2011
21394287	Cell type-specific release of matrix-metallo-proteinase-9 by bacterial chemoattractant in human blood phagocytic leukocytes.	International Journal of Clinical and Experimental Medicine (discontinued)	2011
21511696	Heme oxygenase-1 induction contributes to renoprotection by G-CSF during rhabdomyolysis-associated acute kidney injury.		2011
21498625	Bacterial LPS up-regulated TLR3 expression is critical for antiviral response in human monocytes: evidence for negative regulation by CYLD.	International Immunology	2011
21633170	Inhibition of PKCÎ´ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer.	J Clin Invest	2011